SGA400
Articular Osteoarthritis (for cartilage lubrication and pain reduction)
DevelopmentActive
Key Facts
Indication
Articular Osteoarthritis (for cartilage lubrication and pain reduction)
Phase
Development
Status
Active
Company
About BMG Pharma
BMG Pharma is a privately-held, development-stage Italian biotech firm specializing in advanced biomaterials. Its core asset is the Hyaluromimethic® technology platform, which is being applied to create injectable products for osteoarthritis, regenerative medicine, ophthalmology, and aesthetic medicine. The company has recently undergone a strategic reorganization, is actively engaged in R&D supported by public grants, and appears to be transitioning its focus towards higher-value therapeutic applications. Its business model combines platform development with B2B partnerships for product commercialization.
View full company profile